Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) Shares Outstanding (Diluted Average) (2016 - 2025)

MedWellAI (MWAI) has disclosed Shares Outstanding (Diluted Average) for 10 consecutive years, with $6.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 19.84% to $6.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.2 million, a 19.84% increase, with the full-year FY2025 number at $5.7 million, up 29.28% from a year prior.
  • Shares Outstanding (Diluted Average) was $6.2 million for Q4 2025 at MedWellAI, up from $6.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $291.2 million in Q4 2021 to a low of $1.6 million in Q1 2022.
  • A 5-year average of $56.3 million and a median of $5.1 million in 2024 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): skyrocketed 154.97% in 2021, then tumbled 99.35% in 2022.
  • MedWellAI's Shares Outstanding (Diluted Average) stood at $291.2 million in 2021, then crashed by 99.35% to $1.9 million in 2022, then skyrocketed by 122.81% to $4.2 million in 2023, then increased by 22.98% to $5.2 million in 2024, then rose by 19.84% to $6.2 million in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Shares Outstanding (Diluted Average) are $6.2 million (Q4 2025), $6.2 million (Q3 2025), and $5.7 million (Q2 2025).